Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

84.43 USD +2.36 (+2.88%)
Streaming Delayed Price Updated: 1:56 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Arrowhead Pharma

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Arrowhead Pharmaceuticals, Inc. - ARWR
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Arrowhead Pharmaceuticals, Inc. securities (NASDAQ:ARWR) from May 11, 2015... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017
Levi & Korsinsky reminds shareholders of ARWR of commencement of a class action lawsuit. 
From Business Wire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Arrowhead Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of... 
From GlobeNewswire News Releases
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Arrowhead Pharmaceuticals, Inc. (ARWR) and Lead Plaintiff Deadline: January 16, 2017
From ACCESSWIRE
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Arrowhead Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Arrowhead Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm 
From Business Wire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
ARWR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Shareholders of Commencement of a Class Action Involving Arrowhead Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 20
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced on behalf of investors who purchased Arrowhead Pharmaceuticals, Inc. securities 
From Business Wire News Releases
Arrowhead Reports Fiscal 2016 Year End Results
Arrowhead reports fiscal 2016 fourth quarter and year ended September 30, 2016, and is hosting a conference call at 4:30 p.m. EST to discuss results 
From Business Wire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Arrowhead Pharmaceuticals, Inc. (ARWR) & Lead Plaintiff Deadline: January 16, 2017
From ACCESSWIRE
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
ARWR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Arrowhead Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Arrowhead... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
ARWR NOTICE: Rosen Law Firm Reminds Arrowhead Pharmaceuticals, Inc. Investors of Important Deadline in Class Action - ARWR
Rosen Law Firm Representing Arrowhead Pharmaceuticals, Inc. Shareholders in Securities Class Action Lawsuit Seeking to Recover Investor Losses - ARWR 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results
Arrowhead Pharmaceuticals will report fiscal 2016 year end results on Dec. 14 
From Business Wire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
EXPANDED CLASS PERIOD: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – ARWR
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Arrowhead Pharmaceuticals, Inc. (ARWR) & Lead Plaintiff Deadline: January 16, 2017
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Arrowhead Pharmaceuticals, Inc. (“Arrowhead” or the “Company”)... 
From GlobeNewswire News Releases
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact
Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Arrowhead Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Arrowhead Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm 
From Business Wire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Arrowhead Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 - ARWR
From ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.